Ultracet and Splenomegaly - a phase IV clinical study of FDA data

Summary:

Splenomegaly is reported as a side effect among people who take Ultracet (acetaminophen; tramadol hydrochloride), especially for people who are male, 20-29 old, also take Levaquin, and have Hypercalcaemia of malignancy.

The phase IV clinical study analyzes which people have Splenomegaly when taking Ultracet. It is created by eHealthMe based on reports of 6,139 people who have side effects when taking Ultracet from the FDA, and is updated regularly.

What is Ultracet?

Ultracet has active ingredients of acetaminophen; tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 6,351 Ultracet users. Check the latest studies of Ultracet.

What is Splenomegaly?

Splenomegaly (enlargement of spleen) is found to be associated with 1,122 drugs and 1,477 conditions by eHealthMe. Check the latest studies of Splenomegaly.

On Jul, 06, 2026

6,139 people reported to have side effects when taking Ultracet.
Among them, 14 people (0.23%) have Splenomegaly.

Among these 14 people:

What is the gender of people who have Splenomegaly when taking Ultracet? *

female: 50 %
male: 50 %

What is the age of people who have Splenomegaly when taking Ultracet? *

What are other drugs people take besides Ultracet? *

Levaquin: 6 people, 42.86%
Zometa: 5 people, 35.71%
Aspirin: 5 people, 35.71%
Desonide: 5 people, 35.71%
Difluprednate: 5 people, 35.71%
Indomethacin: 5 people, 35.71%
Lortab: 5 people, 35.71%
Avelox: 5 people, 35.71%
Revlimid: 5 people, 35.71%
Chlorhexidine Gluconate: 5 people, 35.71%

What are other side effects people have besides Splenomegaly? *

Dyspnea (difficult or laboured breathing): 7 people, 50.00%
Fever: 7 people, 50.00%
Constipation: 6 people, 42.86%
Foot Deformity (functional disability of foot): 6 people, 42.86%
Osteopenia (a condition where bone mineral density is lower than normal): 6 people, 42.86%
Emotional Distress: 6 people, 42.86%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 6 people, 42.86%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 6 people, 42.86%
Pleural Effusion (water on the lungs): 6 people, 42.86%
Pneumonia: 6 people, 42.86%

What are the existing conditions these people have? *

Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 5 people, 35.71%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 21.43%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 14.29%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 7.14%
Pancreatitis Chronic (chronic inflammation of pancreas): 1 person, 7.14%
Insomnia (sleeplessness): 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 7.14%
Chronic Renal Failure (kidney failure): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ultracet and have Splenomegaly?

- Check whether Splenomegaly is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ultracet:

Ultracet (6,351 reports)

Splenomegaly treatments and more:

Splenomegaly (17,257 reports)

How severe was Splenomegaly and when was it recovered:

Splenomegaly in Ultracet

Expand to all the drugs that have ingredients of acetaminophen; tramadol hydrochloride:

Splenomegaly and drugs with ingredients of acetaminophen; tramadol hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ultracet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Splenomegaly:

Splenomegaly (1,122 drugs)

Browse all the conditions that are associated with Splenomegaly:

Splenomegaly (1,477 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; tramadol hydrochloride (the active ingredients of Ultracet) and Ultracet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.